DAIICHI SANKYO AND ARQULE ANNOUNCE TOP-LINE RESULTS OF PHASE 2 TRIAL WITH TIVANTINIB IN COLORECTAL CANCER

[at noodls] – For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO (Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address … more

View todays social media effects on ARQL

View the latest stocks trending across Twitter. Click to view dashboard

See who ArQule is hiring next, click here to view